UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 635

Sortiert nach

Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids

Proceedings of the National Academy of Sciences - PNAS, 2012-05, Vol.109 (22), p.8546-8551

2012

Volltextzugriff (PDF)

Intraoperative cardiac arrest in the lateral position: Is rapid repositioning always necessary?

Anaesthesia and intensive care, 2023-05, Vol.51 (3), p.217-218

2023

Volltextzugriff (PDF)

Prolonged evolution of the human B cell response to SARS-CoV-2 infection

Science immunology, 2021-02, Vol.6 (56)

2021

Volltextzugriff (PDF)

A multicentre review of the direct-access mammography programme in Ireland for women with breast pain

Clinical radiology, 2024-02, Vol.79 (2), p.e227-e231

2024

Volltextzugriff (PDF)

Evolution of antibody immunity following Omicron BA.1 breakthrough infection

Nature communications, 2023-05, Vol.14 (1), p.2751-2751, Article 2751

2023

Volltextzugriff (PDF)

Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering

mAbs, 2016-07, Vol.8 (5), p.941-950

2016

Volltextzugriff (PDF)

A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties

PloS one, 2016-12, Vol.11 (12), p.e0167935-e0167935

2016

Volltextzugriff (PDF)

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

The EMBO journal, 2003-12, Vol.22 (23), p.6267-6276

2003

Volltextzugriff (PDF)

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Science (American Association for the Advancement of Science), 2021-02, Vol.371 (6531), p.823-829

2021

Volltextzugriff (PDF)

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

Bone (New York, N.Y.), 2004-10, Vol.35 (4), p.828-835

2004

Volltextzugriff (PDF)

Protease-resistant Prion Protein Amplification Reconstituted with Partially Purified Substrates and Synthetic Polyanions

The Journal of biological chemistry, 2005-07, Vol.280 (29), p.26873-26879

2005

Volltextzugriff (PDF)

Dissociation of infectivity from seeding ability in prions with alternate docking mechanism

PLoS pathogens, 2011-07, Vol.7 (7), p.e1002128-e1002128

2011

Volltextzugriff (PDF)

RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1

Neurobiology of disease, 2013-08, Vol.56, p.6-13

2013

Volltextzugriff (PDF)

The Geoid Slope Validation Survey 2014 and GRAV-D airborne gravity enhanced geoid comparison results in Iowa

Journal of geodesy, 2017-10, Vol.91 (10), p.1261-1276

2017

Volltextzugriff (PDF)

Selective Incorporation of Polyanionic Molecules into Hamster Prions

The Journal of biological chemistry, 2007-12, Vol.282 (50), p.36341-36353

2007

Volltextzugriff (PDF)

Sclerostin Inhibition of Wnt-3a-induced C3H10T1/2 Cell Differentiation Is Indirect and Mediated by Bone Morphogenetic Proteins

The Journal of biological chemistry, 2005-01, Vol.280 (4), p.2498-2502

2005

Volltextzugriff (PDF)

Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor

PLoS pathogens, 2009-07, Vol.5 (7), p.e1000535-e1000535

2009

Volltextzugriff (PDF)

Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts

Bone (New York, N.Y.), 2004-08, Vol.35 (2), p.448-454

2004

Volltextzugriff (PDF)

Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex

The Journal of biological chemistry, 2004-08, Vol.279 (35), p.36293-36298

2004

Volltextzugriff (PDF)

Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure

Molecular therapy. Nucleic acids, 2012-11, Vol.1 (11), p.e53-e53, Article e53

2012

Volltextzugriff (PDF)

Species-Dependent Differences in Cofactor Utilization for Formation of the Protease-Resistant Prion Protein in Vitro

Biochemistry (Easton), 2010-05, Vol.49 (18), p.3928-3934

2010

Volltextzugriff (PDF)

Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein

Immunity (Cambridge, Mass.), 2022-09, Vol.55 (9), p.1710-1724.e8

2022

Volltextzugriff (PDF)

Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers

Science translational medicine, 2023-03, Vol.15 (688), p.eadg2783

2023

Volltextzugriff (PDF)

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action

mAbs, 2016-04, Vol.8 (3), p.454-467

2016

Volltextzugriff (PDF)

61. Effect of parity on dairy cow mobility and subsequent milk yield, feed intake and feed efficiency during lactation

Animal - Science Proceedings, 2022-04, Vol.13 (1), p.40-40

2022

Volltextzugriff (PDF)

1 – 25 von 635

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(547)
Mit Volltextzugriff
(560)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(384)
Life Sciences & Biomedicine
(332)
Humans
(213)
Animals
(95)
Female
(92)
Male
(90)
Biological And Medical Sciences
(67)
Biochemistry & Molecular Biology
(59)
Middle Aged
(57)
Adult
(56)
Surgery
(49)
Medical Sciences
(42)
Virology
(41)
Mice
(39)
Aged
(37)
Radiology, Nuclear Medicine & Medical Imaging
(32)
Fundamental And Applied Biological Sciences. Psychology
(31)
Physical Sciences
(31)
Proteins
(29)
Science & Technology - Other Topics
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids

Intraoperative cardiac arrest in the lateral position: Is rapid repositioning always necessary?

Prolonged evolution of the human B cell response to SARS-CoV-2 infection

A multicentre review of the direct-access mammography programme in Ireland for women with breast pain

Evolution of antibody immunity following Omicron BA.1 breakthrough infection

Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering

A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

Protease-resistant Prion Protein Amplification Reconstituted with Partially Purified Substrates and Synthetic Polyanions

Dissociation of infectivity from seeding ability in prions with alternate docking mechanism

RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1

The Geoid Slope Validation Survey 2014 and GRAV-D airborne gravity enhanced geoid comparison results in Iowa

Selective Incorporation of Polyanionic Molecules into Hamster Prions

Sclerostin Inhibition of Wnt-3a-induced C3H10T1/2 Cell Differentiation Is Indirect and Mediated by Bone Morphogenetic Proteins

Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor

Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts

Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex

Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure

Species-Dependent Differences in Cofactor Utilization for Formation of the Protease-Resistant Prion Protein in Vitro

Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein

Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action

61. Effect of parity on dairy cow mobility and subsequent milk yield, feed intake and feed efficiency during lactation

Suchergebnisse filtern